- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.05. | Digital player Hinge Health rises sharply after NYSE debut | ||
| 22.05. | AZ partners with Aptar on kidney disease-detecting AI | ||
| 22.05. | Sanofi makes Alzheimer's play with Vigil Neuroscience takeover | ||
| 22.05. | Pfizer's weekly haemophilia drug backed for NHS use | ||
| 22.05. | FDA tightens heart tox warnings on mRNA COVID vaccines | ||
| 22.05. | Mixed outcomes for pharma in big week for FDA adcomms | ||
| 21.05. | US imposes limits on COVID-19 boosters and new jabs | ||
| 21.05. | UK to start "world first" gonorrhoea vaccine programme | ||
| 21.05. | Beckley's psychedelic med inches forward in depression | ||
| 21.05. | UK trumpets £1bn investment plan from BioNTech | ||
| 21.05. | First details of Trump's most favoured nation plan emerge | ||
| 20.05. | O'Shaughnessy says UK clinical trials sector is on the mend | ||
| 20.05. | Imec showcases ingestible sensor for gut studies | ||
| 20.05. | UK's long-term R&D investment policy welcomed | ||
| 20.05. | Pfizer snaps up PD-1/VEGF drug from China's 3SBio | ||
| 19.05. | Regeneron swoops on genetic testing firm 23andMe | ||
| 19.05. | Partner of ex-Theranos CEO raising cash for testing start-up | ||
| 19.05. | Japan follows UK in GSK's comeback tour for Blenrep | ||
| 19.05. | Partner of ex-Theranos CEO raising cash for testing startup | ||
| 19.05. | BioMarin starts rebuilding after its downsizing spree | ||
| 16.05. | Novo Nordisk's dropping share price spells the end for CEO | ||
| 16.05. | Incyte's PD-1 drug brings immunotherapy to anal cancer | ||
| 16.05. | Pathos AI's big $365m Series D, and other bio financings | ||
| 16.05. | Datavant, Aetion merger creates real-world data force | ||
| 16.05. | World first as infant gets personalised CRISPR therapy |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .